Editorial: Personalizing Treatment in IBD: Hype or Reality in 2020?

Frontiers in Medicine

article

Fernando Gomollón¹  Edouard Louis² 

[1] Inflammatory Bowel Disease (IBD) Unit, Department of Medicine, Hospital Clínico Universitario “Lozano Blesa”, Instituto de Investigación Sanitaria de Aragón (IIS) Aragón;Department of Gastroenterology, University and Centre Hospitalaire Univestitaire (CHU) Liège

关键词: personalized;    IBD;    Crohn's disease;    ulcerative colitis;    prediction;   

DOI  :  10.3389/fmed.2021.673991

学科分类：社会科学、人文和艺术（综合）

来源: Frontiers

【 摘 要 】

Let us go to the daily clinic. Ana Isabel, Raúl, and José Luis are the real names of three of IBD (inflammatory bowel disease) patients to be seen tomorrow at the office. We will share information on their symptoms, tests results, treatment plans and worries for the following months. We are confident, for instance, that they will ask about the convenience of the COVID vaccination. Some of their questions will be very easy to answer, but things will get complicated if they ask me about the future. For instance, Ana Isabel could ask: Can I stop my infliximab? And our response would, should, and will be: we do not know. An apparently simple question is not so simple. As we do love books, we will, first, quote some recent ones for establishing context.

【 授权许可】

CC BY